FDA-approved TMS refers to Transcranial Magnetic Stimulation (TMS) therapy systems and treatment protocols that have been reviewed and cleared or approved by the U.S. Food and Drug Administration (FDA) for specific medical and mental health conditions. FDA clearance means that the treatment has undergone scientific evaluation for safety and effectiveness for designated uses.
FDA-approved TMS is commonly used to treat Major Depressive Disorder (MDD), treatment-resistant depression, Obsessive-Compulsive Disorder (OCD), and certain anxiety symptoms associated with depression in eligible patients.
FDA-approved TMS therapy uses magnetic pulses to stimulate targeted areas of the brain involved in mood regulation, emotional processing, and behavior. During treatment, a specialized device delivers magnetic stimulation through a treatment coil placed against the scalp.
The magnetic pulses pass through the skull and activate nerve cells in specific brain regions associated with depression and other mental health conditions.
Treatment is:
Patients remain awake and alert during treatment and can usually resume normal activities immediately afterward.
The FDA has cleared certain TMS systems for specific conditions, including:
Treatment eligibility is determined through a comprehensive psychiatric evaluation and review of an individual’s medical history.
FDA-approved TMS offers several potential benefits, including:
Many individuals experience meaningful symptom improvement after completing a full course of treatment.
FDA-approved TMS has been extensively studied and is generally considered safe and well tolerated when administered by qualified providers. The most common side effects include mild scalp discomfort, headaches, or facial muscle twitching during treatment.
Although rare, seizures can occur in a very small percentage of patients. Individuals with certain implanted metal devices or non-removable conductive metal near the head may not be eligible for treatment.
A qualified mental health provider can determine whether FDA-approved TMS is appropriate based on an individual’s medical history and treatment needs.
At Pinnacle Behavioral Healthcare, we proudly offer Pinnacle TMS using the NeuroStar Advanced Therapy System, an FDA-cleared treatment option for eligible patients experiencing depression, OCD, and related conditions.
Our experienced providers perform comprehensive evaluations and create individualized treatment plans that may also include Medication Management, Individual Psychotherapy, and Spravato Therapy.
If you would like to learn more about FDA-approved TMS therapy, schedule a consultation with our team today.
FDA-approved or FDA-cleared TMS means that the treatment system has been reviewed by the U.S. Food and Drug Administration and determined to be safe and effective for specific medical uses.
Yes. The NeuroStar Advanced Therapy System has received FDA clearance for the treatment of Major Depressive Disorder, anxiety symptoms associated with depression, Obsessive-Compulsive Disorder, and certain adolescent depression indications.
Many insurance providers cover FDA-approved TMS therapy for eligible patients, particularly those with treatment-resistant depression. Coverage requirements vary by insurance plan.
No. TMS is a non-drug treatment option. However, some patients may receive TMS alongside medication management or psychotherapy as part of a comprehensive treatment plan.
Individuals with depression, treatment-resistant depression, OCD, or other eligible conditions may qualify for TMS therapy. A comprehensive psychiatric evaluation is required to determine candidacy.
